Company Filing History:
1 out of 2,318 
1 out of 154 Years Active: 2009
Title: Emily C Gillespie: Innovator in Diagnosing Systemic Lupus Erythematosus
Introduction
Emily C Gillespie is a notable inventor based in Savage, MN (US). She has made significant contributions to the field of medical diagnostics, particularly in relation to systemic lupus erythematosus (SLE). Her innovative work has the potential to improve the diagnosis and treatment of this complex autoimmune disease.
Latest Patents
Emily holds a patent related to systemic lupus erythematosus, which encompasses methods and materials for diagnosing SLE. This patent provides nucleic acid arrays that can be utilized to diagnose SLE in mammals. These arrays enable clinicians to determine the expression levels of various genes that are differentially expressed in SLE patients compared to healthy individuals. Additionally, her patent includes methods for assessing SLE activity, predicting the likelihood of experiencing active SLE, and evaluating the effectiveness of SLE treatments. Emily has 1 patent to her name.
Career Highlights
Throughout her career, Emily has worked with esteemed institutions such as the University of Minnesota and The Feinstein Institutes for Medical Research. Her research has focused on advancing the understanding and diagnosis of systemic lupus erythematosus, contributing to the medical community's efforts to combat this challenging condition.
Collaborations
Emily has collaborated with notable colleagues, including Timothy W Behrens and Peter Gregersen. These partnerships have further enriched her research and innovation in the field of autoimmune diseases.
Conclusion
Emily C Gillespie is a pioneering inventor whose work in diagnosing systemic lupus erythematosus has the potential to transform patient care. Her contributions to medical diagnostics highlight the importance of innovation in addressing complex health challenges.